Chinese tech giants Tencent, Alibaba, and ByteDance are ramping up orders for Nvidia’s (NASDAQ: NVDA) H20 AI chip due to soaring demand for DeepSeek’s cost-efficient AI models, sources told Reuters. This surge highlights Nvidia’s dominance in China’s AI sector, even as U.S. export restrictions limit its offerings.
The H20, specifically designed for the Chinese market, has seen a sharp increase in demand since DeepSeek’s AI models gained global recognition last month. Beyond their own AI needs, these companies offer cloud computing services, further driving demand for Nvidia’s chips. Smaller firms in healthcare and education are also investing in AI servers equipped with DeepSeek models and H20 chips.
While potential U.S. restrictions on H20 sales to China loom, industry insiders attribute the growing demand primarily to DeepSeek’s AI capabilities. The models prioritize inference efficiency, reducing reliance on raw processing power, which has fueled their adoption across industries.
A market shakeup in January saw Nvidia shares drop nearly 20% due to concerns that DeepSeek might reduce AI chip demand. However, the stock has since rebounded, down just 3% year-to-date. Analysts estimate Nvidia shipped roughly 1 million H20 units in 2024, generating over $12 billion in revenue. Despite efforts by Chinese chipmakers like Huawei to compete, Nvidia’s H20 remains the industry standard.
Companies including Tencent and Great Wall Motors have already announced plans to integrate DeepSeek’s AI models into their platforms. As AI adoption accelerates in China, Nvidia’s position in the market remains strong, reinforcing its crucial role in the country’s AI infrastructure.


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 



